330 related articles for article (PubMed ID: 28380412)
1. β-Asarone promotes Temozolomide's entry into glioma cells and decreases the expression of P-glycoprotein and MDR1.
Wang N; Zhang Q; Ning B; Luo L; Fang Y
Biomed Pharmacother; 2017 Jun; 90():368-374. PubMed ID: 28380412
[TBL] [Abstract][Full Text] [Related]
2. β-asarone inhibited cell growth and promoted autophagy via P53/Bcl-2/Bclin-1 and P53/AMPK/mTOR pathways in Human Glioma U251 cells.
Wang N; Zhang Q; Luo L; Ning B; Fang Y
J Cell Physiol; 2018 Mar; 233(3):2434-2443. PubMed ID: 28776671
[TBL] [Abstract][Full Text] [Related]
3. β-asarone induces cell apoptosis, inhibits cell proliferation and decreases migration and invasion of glioma cells.
Wang N; Han Y; Luo L; Zhang Q; Ning B; Fang Y
Biomed Pharmacother; 2018 Oct; 106():655-664. PubMed ID: 29990855
[TBL] [Abstract][Full Text] [Related]
4. β-Asarone Inhibits Invasion and EMT in Human Glioma U251 Cells by Suppressing Splicing Factor HnRNP A2/B1.
Li L; Wu M; Wang C; Yu Z; Wang H; Qi H; Xu X
Molecules; 2018 Mar; 23(3):. PubMed ID: 29547514
[TBL] [Abstract][Full Text] [Related]
5. Chemoresistance to temozolomide in human glioma cell line U251 is associated with increased activity of O6-methylguanine-DNA methyltransferase and can be overcome by metronomic temozolomide regimen.
Pan Q; Yang XJ; Wang HM; Dong XT; Wang W; Li Y; Li JM
Cell Biochem Biophys; 2012 Jan; 62(1):185-91. PubMed ID: 21892781
[TBL] [Abstract][Full Text] [Related]
6. Long Non-Coding RNA MALAT1 Decreases the Sensitivity of Resistant Glioblastoma Cell Lines to Temozolomide.
Li H; Yuan X; Yan D; Li D; Guan F; Dong Y; Wang H; Liu X; Yang B
Cell Physiol Biochem; 2017; 42(3):1192-1201. PubMed ID: 28668966
[TBL] [Abstract][Full Text] [Related]
7. Temozolomide inhibits cellular growth and motility via targeting ERK signaling in glioma C6 cells.
Wang Y; Gao S; Wang W; Liang J
Mol Med Rep; 2016 Dec; 14(6):5732-5738. PubMed ID: 27878252
[TBL] [Abstract][Full Text] [Related]
8. Combination of photodynamic therapy and temozolomide on glioma in a rat C6 glioma model.
Zhang X; Guo M; Shen L; Hu S
Photodiagnosis Photodyn Ther; 2014 Dec; 11(4):603-12. PubMed ID: 25449156
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of BRCA1-BRCA2-containing complex subunit 3 sensitizes glioma cells to temozolomide.
Chai KM; Wang CY; Liaw HJ; Fang KM; Yang CS; Tzeng SF
Oncotarget; 2014 Nov; 5(21):10901-15. PubMed ID: 25337721
[TBL] [Abstract][Full Text] [Related]
10. Downregulation of HIF-1a sensitizes U251 glioma cells to the temozolomide (TMZ) treatment.
Tang JH; Ma ZX; Huang GH; Xu QF; Xiang Y; Li N; Sidlauskas K; Zhang EE; Lv SQ
Exp Cell Res; 2016 May; 343(2):148-158. PubMed ID: 27090014
[TBL] [Abstract][Full Text] [Related]
11. Knockdown of RLIP76 expression by RNA interference inhibits invasion, induces cell cycle arrest, and increases chemosensitivity to the anticancer drug temozolomide in glioma cells.
Wang Q; Qian J; Wang J; Luo C; Chen J; Hu G; Lu Y
J Neurooncol; 2013 Mar; 112(1):73-82. PubMed ID: 23292182
[TBL] [Abstract][Full Text] [Related]
12. Temozolomide competes for P-glycoprotein and contributes to chemoresistance in glioblastoma cells.
Munoz JL; Walker ND; Scotto KW; Rameshwar P
Cancer Lett; 2015 Oct; 367(1):69-75. PubMed ID: 26208431
[TBL] [Abstract][Full Text] [Related]
13. KLF8 Promotes Temozolomide Resistance in Glioma Cells via β-Catenin Activation.
Yu G; Wu F; Wang E
Cell Physiol Biochem; 2016; 38(4):1596-604. PubMed ID: 27081861
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of ILK promotes temozolomide resistance in glioma cells.
Liang F; Wang B; Bao L; Zhao YS; Zhang SM; Zhang SQ
Mol Med Rep; 2017 Mar; 15(3):1297-1304. PubMed ID: 28138714
[TBL] [Abstract][Full Text] [Related]
15. The synergistic therapeutic effect of temozolomide and hyperbaric oxygen on glioma U251 cell lines is accompanied by alterations in vascular endothelial growth factor and multidrug resistance-associated protein-1 levels.
Lu XY; Cao K; Li QY; Yuan ZC; Lu PS
J Int Med Res; 2012; 40(3):995-1004. PubMed ID: 22906272
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of EZH2 reverses chemotherapeutic drug TMZ chemosensitivity in glioblastoma.
Fan TY; Wang H; Xiang P; Liu YW; Li HZ; Lei BX; Yu M; Qi ST
Int J Clin Exp Pathol; 2014; 7(10):6662-70. PubMed ID: 25400745
[TBL] [Abstract][Full Text] [Related]
17. Trans-1-amino-3-18F-fluorocyclobutanecarboxylic acid (anti-18F-FACBC) is a feasible alternative to 11C-methyl-L-methionine and magnetic resonance imaging for monitoring treatment response in gliomas.
Sasajima T; Ono T; Shimada N; Doi Y; Oka S; Kanagawa M; Baden A; Mizoi K
Nucl Med Biol; 2013 Aug; 40(6):808-15. PubMed ID: 23701701
[TBL] [Abstract][Full Text] [Related]
18. NVP-BEZ235, a novel dual PI3K-mTOR inhibitor displays anti-glioma activity and reduces chemoresistance to temozolomide in human glioma cells.
Yu Z; Xie G; Zhou G; Cheng Y; Zhang G; Yao G; Chen Y; Li Y; Zhao G
Cancer Lett; 2015 Oct; 367(1):58-68. PubMed ID: 26188279
[TBL] [Abstract][Full Text] [Related]
19. DNMT1 mediates chemosensitivity by reducing methylation of miRNA-20a promoter in glioma cells.
Zhou D; Wan Y; Xie D; Wang Y; Wei J; Yan Q; Lu P; Mo L; Xie J; Yang S; Qi X
Exp Mol Med; 2015 Sep; 47(9):e182. PubMed ID: 26337869
[TBL] [Abstract][Full Text] [Related]
20. β-Asarone Induces Apoptosis and Cell Cycle Arrest of Human Glioma U251 Cells via Suppression of HnRNP A2/B1-Mediated Pathway In Vitro and In Vivo.
Li L; Yang Y; Wu M; Yu Z; Wang C; Dou G; He H; Wang H; Yang N; Qi H; Xu X
Molecules; 2018 May; 23(5):. PubMed ID: 29751524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]